NovoCure (NVCR) Revenue Growth (3y) (2017 - 2026)
NovoCure (NVCR) Revenue Growth (3y) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.07 Bn | 193.46 Bn | 7.27 Bn | 8.07% |
| 2 | Stryker | 127.90 Bn | 124.43 Bn | 4.50 Bn | 9.66% |
| 3 | Medtronic | 118.84 Bn | 109.62 Bn | 6.41 Bn | 4.70% |
| 4 | Boston Scientific | 73.33 Bn | 72.79 Bn | 3.85 Bn | 14.78% |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn | 10.83% |
| 6 | Dexcom | 34.46 Bn | 32.51 Bn | 830.00 Mn | 14.51% |
| 7 | GE HealthCare Technologies | 33.91 Bn | 31.81 Bn | 2.18 Bn | 3.20% |
| 8 | Koninklijke Philips | 26.36 Bn | 23.04 Bn | 4.55 Bn | 25.44% |
| 9 | Steris | 23.12 Bn | 22.64 Bn | 684.20 Mn | 8.05% |
| 10 | NovoCure | 2.03 Bn | 1.59 Bn | 142.48 Mn | 13.35% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 13.35% |
| Mar 31, 2026 | 12.52% |
| Dec 31, 2025 | 10.73% |
| Sep 30, 2025 | 8.47% |
| Jun 30, 2025 | 4.08% |
| Mar 31, 2025 | 4.06% |
| Dec 31, 2024 | 6.58% |
| Sep 30, 2024 | 5.10% |
| Jun 30, 2024 | 4.04% |
| Mar 31, 2024 | 0.93% |
| Dec 31, 2023 | -2.41% |
| Sep 30, 2023 | -1.36% |
| Jun 30, 2023 | 2.83% |
| Mar 31, 2023 | 6.26% |
| Dec 31, 2022 | 8.98% |
| Sep 30, 2022 | 12.48% |
| Jun 30, 2022 | 17.55% |
| Mar 31, 2022 | 23.34% |
| Dec 31, 2021 | 24.12% |
| Sep 30, 2021 | 27.31% |